LONDON, UK: Belluscura plc (AIM: BELL), a leading medical device developer focused on lightweight and portable oxygen enrichment technology, announced that early results on the two-month-old direct to consumer program have exceeded the Board’s initial expectations. The company has introduced a three-prong direct sales, leasing and short-term rental program for its established X-PLOR® device that…